A Case of Parotid Gland Fistula After Microtia Reconstruction Successfully Treated With Botulinum Toxin Type A

被引：0
|
作者：
Zhang, Bo [1 ]
Xu, Suqi [1 ]
Li, Gaofeng [1 ]
Ding, Wei [1 ]
Long, Xiren [1 ]
Fu, Anqi [1 ]
机构：
[1] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Plast & Laser Cosmetol, 61 Jiefang Xi Rd, Changsha 410005, Hunan, Peoples R China
来源：
ENT-EAR NOSE & THROAT JOURNAL | 2024年 / 103卷 / 03期
关键词：
parotid gland fistula; botulinum toxin type A; microtia reconstruction; delayed postauricular skin flap; COMPLICATION;
D O I：
10.1177/01455613211038325
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Parotid gland fistula after microtia reconstruction is relatively rare, with only 3 cases having been reported in the literature. It may be caused by the presence of an accessory parotid gland or surgical damage to parotid gland tissues. The principal treatment is dressing the wound. Here, we report the first case of parotid fistula after microtia reconstruction using a delayed retroauricular flap, which healed following wound dressing and an injection of botulinum toxin type A (CBTXA) into the parotid gland.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
  • [41] Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
    Stengel, Gabriele
    Bee, Eva Kristina
    CLINICAL INTERVENTIONS IN AGING, 2011, 6 : 281 - 284
  • [42] Motor control testing of upper limb function after botulinum toxin injection: A case study
    Hurvitz, EA
    Conti, GE
    Flansburg, EL
    Brown, SH
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2000, 81 (10): : 1408 - 1415
  • [43] Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
    Shackley, Phil
    Shaw, Lisa
    Price, Christopher
    van Wijck, Frederike
    Barnes, Michael
    Graham, Laura
    Ford, Gary A.
    Steen, Nick
    Rodgers, Helen
    TOXINS, 2012, 4 (12): : 1415 - 1426
  • [44] Disabling Overactivity of the extensor hallucis longus after stroke: Clinical expression and efficacy of botulinum toxin type A
    Yelnik, AP
    Colle, FM
    Bonan, IV
    Lamotte, DR
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (01): : 147 - 149
  • [45] Effective pain palliation in Fibromyalgia syndrome patients with botulinum toxin type-A: Case series of 25
    Ko, Gordon D.
    Whitmore, Scott
    Huang, David
    McDonald, Robert
    JOURNAL OF MUSCULOSKELETAL PAIN, 2007, 15 (04): : 55 - 66
  • [46] Botulinum Toxin Type a for Treating Rest Pain in Chronic Limb-threatening Ischemia: A Case Report
    Xu, Jiaoxiong
    Lin, Haofeng
    VASCULAR AND ENDOVASCULAR SURGERY, 2023, 57 (08) : 927 - 931
  • [47] Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: A case series
    Charrow, Alexandra
    DiFazio, Marc
    Foster, Leslie
    Pasquina, Paul F.
    Tsao, Jack W.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (07): : 1407 - 1409
  • [48] EFFECTIVENESS OF SWITCHING THERAPY FROM COMPLEXING PROTEIN-CONTAINING BOTULINUM TOXIN TYPE A TO A FORMULATION WITH LOW IMMUNOGENICITY IN SPASTICITY AFTER STROKE: A CASE REPORT
    Santamato, Andrea
    Ranieri, Maurizio
    Panza, Francesco
    Frisardi, Vincenza
    Micello, Maria Francesca
    Filoni, Serena
    Fiore, Pietro
    JOURNAL OF REHABILITATION MEDICINE, 2012, 44 (09) : 795 - 797
  • [49] MicroRNA-mRNA expression profiles and functional network after injection of botulinum toxin type A into submandibular glands
    Mao, Qian-Ying
    Xie, Shang
    Wu, Li-Ling
    Xiang, Ruo-Lan
    Cai, Zhi-Gang
    TOXICON, 2021, 199 : 31 - 40
  • [50] Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A: Much Ado About Nothing?
    Lange, Oliver
    Bigalke, Halls
    Dengler, Reinhard
    Wegner, Florian
    deGroot, Michael
    Wohlfarth, Kai
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (04) : 213 - 218
12345